📰 Switch Therapeutics News
Switch Therapeutics News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Switch Therapeutics. Real-time updates on events, politics, business and more.
January 3, 2024
SOUTH SAN FRANCISCO, Calif., January 03, 2024--Switch Therapeutics today announced the appointment of Charles Allerson, Ph.D., as Chief Technology Officer (CTO).
September 6, 2023
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Switch Therapeutics, a biotechnology company pioneering a new way to use RNA science to treat disease, utilizing its proprietary CASi (Conditionally Activated siRNA) platform, today announced that Dee Data, Ph.D., Co-Founder and CEO of Switch Therapeutics, will present a...
August 9, 2023
The Nucleic Acid Based Therapeutics Market size is expected to grow from USD 4.89 billion in 2023 to USD 9.54 billion by 2028, at a CAGR of 14.29% during...
March 24, 2023
Flare Therapeutics, EpiBiologics, and Mbiomics are among the biotech companies that recently unveiled new rounds of financing.
March 15, 2023
Amgen sued over hiding $10.7 billion in taxes and penalties; GSK reveals positive Phase III data for meningococcal vaccine.
March 14, 2023
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
March 14, 2023
Switch Therapeutics announced $52M in early funding to develop conditionally activated small interfering (CASi) RNA therapeutics.